Cargando…
Inhibition of glutaminolysis in combination with other therapies to improve cancer treatment
Targeting glutamine catabolism has been attracting more research attention on the development of successful cancer therapy. Catalytic enzymes such as glutaminase (GLS) in glutaminolysis, a series of biochemical reactions by which glutamine is converted to glutamate and then alpha-ketoglutarate, an i...
Autores principales: | Shen, Yao-An, Chen, Chi-Long, Huang, Yi-Hsuan, Evans, Emily Elizabeth, Cheng, Chun-Chia, Chuang, Ya-Jie, Zhang, Cissy, Le, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570367/ https://www.ncbi.nlm.nih.gov/pubmed/33721588 http://dx.doi.org/10.1016/j.cbpa.2021.01.006 |
Ejemplares similares
-
Therapeutic Targeting of Glutaminolysis as a Novel Strategy to Combat Cancer Stem Cells
por: Kao, Ting-Wan, et al.
Publicado: (2022) -
Inhibition of Glycolysis and Glutaminolysis: An Emerging Drug Discovery Approach to Combat Cancer
por: Akins, Nicholas S., et al.
Publicado: (2018) -
Glutaminolysis gets the spotlight in cancer
por: Herranz, Daniel
Publicado: (2016) -
Inhibition of glutaminolysis restores mitochondrial function in senescent stem cells
por: Choudhury, Debanik, et al.
Publicado: (2022) -
Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis
por: Ahmed, Shanzay, et al.
Publicado: (2023)